Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Commonalities"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
dewey-ones:"140 - Specific philosophical schools"
product_txtF_mv:"National Center for Biotechnology Information"
Search alternatives
:
commonalities »
communities
,
commodities
Showing
1
-
20
of
83
Search:
'"Commonalities"'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Entyvio (Vedolizumab)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
2
Reslizumab (Cinqair)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
3
Tocilizumab (Actemra) : adult patients with moderately to severely active rheumatoid arthritis
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
4
Tocilizumab (Actemra, intravenous) : for the treatment of signs and symptoms of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have r...
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
5
Entyvio (Vedolizumab)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
6
Reslizumab (Cinqair)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
7
Tocilizumab (Actemra) : adult patients with moderately to severely active rheumatoid arthritis
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
8
Tocilizumab (Actemra, intravenous) : for the treatment of signs and symptoms of active polyarticular juvenile idiopathic arthritis in patients two years of age and older who have r...
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...
Common
drug review...
”
Read Now
9
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
10
Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.)
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
11
Patient group input submissions: Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited)
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
12
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
13
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
14
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication: for the treatment of adult patients with active ankylosing spondylitis who have responded i...
Published 2020
CADTH
“
...CADTH
common
drug review...
”
Read Now
15
CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis
Published 2020
CADTH
“
...CADTH
common
drug review...
”
Read Now
16
Pharmacoeconomic review report: Belimumab (Benlysta) (GlaxoSmithKline Inc.) : indication: indicated in addition to standard therapy for reducing disease activity in adult patients...
Published 2020
CADTH
“
...CADTH
common
drug review...
”
Read Now
17
Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : for the treatment of adult patients with active ankylosing spondylitis who have responded inadequa...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
18
CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication : for the treatment of adult patients with moderately to severely acti...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
19
CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
Read Now
20
CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...CADTH
common
drug review...
”
1
2
3
4
5
Back
Narrow Search
Remove Filters
Clear Filter
Classification: 140 - Specific philosophical schools
Clear Filter
Collection: National Center for Biotechnology Information
Year of Publication
From:
To:
Classification
140 - Specific philosophical schools
330 - Economics
29
610 - Medicine & health
28
700 - The arts; fine & decorative arts
23
Language
English
83
Collection
National Center for Biotechnology Information
Author
Canadian Agency for Drugs and Technologies in Health
70
CADTH Canadian Drug Expert Committee
24
Multiple Sclerosis Society of Canada
2
Recently Uploaded
Last Month
5
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=dewey-ones%3A%22140+-+Specific+philosophical+schools%22&filter%5B%5D=product_txtF_mv%3A%22National+Center+for+Biotechnology+Information%22&lookfor=%22Commonalities%22&type=Series
Send by Email
×
Loading...